Weave Announces Date of Second Quarter 2024 Financial Results and Conference Call
Weave Announces Date of Second Quarter 2024 Financial Results and Conference Call
Weave (NYSE: WEAV), a leading all-in-one experience software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the second quarter 2024 after U.S. markets close on Wednesday, July 31, 2024. Company management will host a conference call and webcast at 4:30 p.m. ET to discuss Weave’s financial results and provide a business update.
Individuals interested in listening to the conference call may do so by dialing (412) 902-1020 or toll-free at (877) 502-7186. The live webcast and a webcast replay of the conference call can be accessed from the investor relations page of Weave’s website at investors.getweave.com.
About Weave
Weave is the all-in-one experience platform for small- and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire customer journey. Weave’s software solutions transform how local healthcare providers attract, communicate with, and engage patients to grow their practice. In the past year, Weave has been named a G2 leader in Patient Engagement, Optometry, Dental Practice Management, and Patient Relationship Management software. To learn more, visit getweave.com/newsroom/.
Investor Contact:
Mark McReynolds
Head of Investor Relations
ir@getweave.com
Media Contact:
Natalie House
Senior Director of Content & Communications
pr@getweave.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240717770643/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk